As common changes in gene expression upon treatment with entinostat and JQ1 in the four investigated bladder cancer cell lines, we have discovered an upregulation of p21, FOXO1, and Bim, all of which will at least in part contribute to the observed synergistic effect with cisplatin. The gene discussed is FOXO1; the disease is urinary bladder carcinoma.